Abstract
The identification of protein-coding genes is currently based on the merging of evidence and predictions from a variety of databases that may themselves contain inaccurate and partial information. We have developed a method for mapping accurate interpretations of protein MS-MS data to the genome. This approach enables verification of genes, exons, transcripts and variant transcripts as well as the de novo discovery of novel protein-coding genes. Here we describe improvements in spectral interpretation algorithms, multiple separation techniques, sub-cellular fractionation and novel bioinformatics approaches to characterise more than 14,000 naturally occurring human genes.
Keywords: proteomics, genome, human, genes, protein isoforms, bioinformatics
Current Proteomics
Title: Annotation of the Human Genome by High-Throughput Sequence Analysis of Naturally Occurring Proteins
Volume: 1 Issue: 1
Author(s): Simon J. McGowan, Jonathan Terrett, Clive G. Brown, Paul J. Adam, Louise Aldridge, Jason C. Allen, Bob Amess, Kristian A. Andrews, Martin Barnes and David E. Barnwell
Affiliation:
Keywords: proteomics, genome, human, genes, protein isoforms, bioinformatics
Abstract: The identification of protein-coding genes is currently based on the merging of evidence and predictions from a variety of databases that may themselves contain inaccurate and partial information. We have developed a method for mapping accurate interpretations of protein MS-MS data to the genome. This approach enables verification of genes, exons, transcripts and variant transcripts as well as the de novo discovery of novel protein-coding genes. Here we describe improvements in spectral interpretation algorithms, multiple separation techniques, sub-cellular fractionation and novel bioinformatics approaches to characterise more than 14,000 naturally occurring human genes.
Export Options
About this article
Cite this article as:
McGowan J. Simon, Terrett Jonathan, Brown G. Clive, Adam J. Paul, Aldridge Louise, Allen C. Jason, Amess Bob, Andrews A. Kristian, Barnes Martin and Barnwell E. David, Annotation of the Human Genome by High-Throughput Sequence Analysis of Naturally Occurring Proteins, Current Proteomics 2004; 1 (1) . https://dx.doi.org/10.2174/1570164043488298
DOI https://dx.doi.org/10.2174/1570164043488298 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Harnessing the Tumor Suppressor Function of FOXO as an Alternative Therapeutic Approach in Cancer
Current Drug Targets Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
Current Cancer Drug Targets Cancer Stem Cells in Hematological Disorders: Current and Possible New Therapeutic Approaches
Current Pharmaceutical Biotechnology Importance of P-gp PET Imaging in Pharmacology
Current Pharmaceutical Design Epidemiology and Prevention of Viral Infections in Patients with Hematologic Malignancies
Infectious Disorders - Drug Targets Privileged Scaffolds Targeting Bromodomain-containing Protein 4
Current Topics in Medicinal Chemistry Anti-Gene Strategies to Down-Regulate Gene Expression in Mammalian Cells
Current Pharmaceutical Design Apoptosis in Anthracycline Cardiomyopathy
Current Pediatric Reviews Polymer-Drug Nanoconjugate – An Innovative Nanomedicine: Challenges and Recent Advancements in Rational Formulation Design for Effective Delivery of Poorly Soluble Drugs
Pharmaceutical Nanotechnology Proteomics in the Search for Biomarkers of Animal Cancer
Current Protein & Peptide Science Biosafety Challenges for Use of Lentiviral Vectors in Gene Therapy
Current Gene Therapy New Approaches to Target Cancer Stem Cells: Current Scenario
Mini-Reviews in Medicinal Chemistry Contrast Enhanced Sonography for Diagnosis of (Peri-) Splenic Pathology
Current Medical Imaging The Combination of Conventional Chemotherapy with New Targeted Therapy in Hematologic Malignancies: The Safety and Efficiency of Low- Dose Cytarabine Supports its Combination with New Therapeutic Agents in Early Clinical Trials
Current Cancer Therapy Reviews Drug Treatment of Obesity: Established and Emerging Therapies
Mini-Reviews in Medicinal Chemistry Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers
Anti-Cancer Agents in Medicinal Chemistry A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor
Current Cancer Drug Targets Small Molecule Inhibition of the Bcl-XL-BH3 Protein-Protein Interaction: Proof-of-Concept of an In Vivo Chemopotentiator ABT-737
Current Topics in Medicinal Chemistry Discovery of Structural Prospects of Imidazo[1,5-a]pyrazine Derivatives as BTK Inhibitors Against Cancer: A Computational Study
Letters in Drug Design & Discovery Induced Stem Cells as a Novel Multiple Sclerosis Therapy
Current Stem Cell Research & Therapy